Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Does IL-17 suppress tumor growth?

Literature DB >> 20339108

Does IL-17 suppress tumor growth?

Shin Foong Ngiow, Mark J Smyth, Michele W L Teng.

Abstract

Entities: Disease Gene

Mesh：

Substances：
Interleukin-17

Year: 2010 PMID： 20339108 DOI： 10.1182/blood-2009-11-254607

Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

Review 1. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.

Authors: Michele W L Teng; Edward P Bowman; Joshua J McElwee; Mark J Smyth; Jean-Laurent Casanova; Andrea M Cooper; Daniel J Cua
Journal: Nat Med Date: 2015-06-29 Impact factor: 53.440

Review 2. Immunomodulatory effects of cyclophosphamide and implementations for vaccine design.

Authors: Antonella Sistigu; Sophie Viaud; Nathalie Chaput; Laura Bracci; Enrico Proietti; Laurence Zitvogel
Journal: Semin Immunopathol Date: 2011-05-25 Impact factor: 11.759

3. Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms.

Authors: Yu Yu; Hyun-Ii Cho; Dapeng Wang; Kane Kaosaard; Claudio Anasetti; Esteban Celis; Xue-Zhong Yu
Journal: J Immunol Date: 2013-01-11 Impact factor: 5.422

4. Th17 cell-derived IL-17A promoted tumor progression via STAT3/NF-κB/Notch1 signaling in non-small cell lung cancer.

Authors: Ruirui Wang; Li Yang; Chaoqi Zhang; Ruijie Wang; Zhen Zhang; Qianyi He; Xinfeng Chen; Bin Zhang; Zhihai Qin; Liping Wang; Yi Zhang
Journal: Oncoimmunology Date: 2018-08-23 Impact factor: 8.110

5. Evaluation of mRNA expression levels of IL-17A and IL-10 cytokines in cervical cancer.

Authors: Setareh Akhavan; Aghdas Safari; Sima Azizmohammadi; Susan Azizmohammadi; Maysam Aslami; Emad Yahaghi; Mehri Seifoleslami
Journal: Tumour Biol Date: 2016-01-29

6. IL-17A/IL-17RA interaction promoted metastasis of osteosarcoma cells.

Authors: Mingmin Wang; Luanqiu Wang; Tao Ren; Lin Xu; Zhenke Wen
Journal: Cancer Biol Ther Date: 2012-11-28 Impact factor: 4.742

7. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.

Authors: Yuting Ma; Laetitia Aymeric; Clara Locher; Stephen R Mattarollo; Nicolas F Delahaye; Pablo Pereira; Laurent Boucontet; Lionel Apetoh; François Ghiringhelli; Noëlia Casares; Juan José Lasarte; Goro Matsuzaki; Koichi Ikuta; Bernard Ryffel; Kamel Benlagha; Antoine Tesnière; Nicolas Ibrahim; Julie Déchanet-Merville; Nathalie Chaput; Mark J Smyth; Guido Kroemer; Laurence Zitvogel
Journal: J Exp Med Date: 2011-03-07 Impact factor: 14.307

Does IL-17 suppress tumor growth?

Review 1. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.

Review 2. Immunomodulatory effects of cyclophosphamide and implementations for vaccine design.

3. Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms.

4. Th17 cell-derived IL-17A promoted tumor progression via STAT3/NF-κB/Notch1 signaling in non-small cell lung cancer.

5. Evaluation of mRNA expression levels of IL-17A and IL-10 cytokines in cervical cancer.

6. IL-17A/IL-17RA interaction promoted metastasis of osteosarcoma cells.

7. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.

8. Trial Watch: Immunostimulatory cytokines.

Review 9. Interleukin-17: a promoter in colorectal cancer progression.

Review 10. Role of T_H17 cytokines in the control of colorectal cancer.

Does IL-17 suppress tumor growth?

Review 1. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.

Review 2. Immunomodulatory effects of cyclophosphamide and implementations for vaccine design.

3. Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms.

4. Th17 cell-derived IL-17A promoted tumor progression via STAT3/NF-κB/Notch1 signaling in non-small cell lung cancer.

5. Evaluation of mRNA expression levels of IL-17A and IL-10 cytokines in cervical cancer.

6. IL-17A/IL-17RA interaction promoted metastasis of osteosarcoma cells.

7. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.

8. Trial Watch: Immunostimulatory cytokines.

Review 9. Interleukin-17: a promoter in colorectal cancer progression.

Review 10. Role of TH17 cytokines in the control of colorectal cancer.

Review 10. Role of T_H17 cytokines in the control of colorectal cancer.